医学
嵌合抗原受体
造血干细胞移植
生活质量(医疗保健)
移植
干细胞
内科学
肿瘤科
免疫学
儿科
癌症
免疫疗法
遗传学
生物
护理部
作者
Kathleen E. Montgomery,Jennifer L. Raybin,Kimberly Powers,Melody Brown Hellsten,Paula Murray,Jessica A. Ward
出处
期刊:Cancer Nursing
[Lippincott Williams & Wilkins]
日期:2024-03-06
卷期号:48 (2): E111-E120
被引量:6
标识
DOI:10.1097/ncc.0000000000001337
摘要
BACKGROUND: Children with cancer and other serious illnesses experience symptom burden during hematopoietic stem cell transplantation and chimeric antigen receptor T-cell therapy, yet limited research has characterized how these symptoms interact with overall quality of life over time. OBJECTIVE: The aim of this study was to examine the longitudinal relationship between symptoms and quality of life in children receiving hematopoietic stem cell transplantation or chimeric antigen receptor T-cell therapy. METHODS: A multisite study design was used to collect symptom and quality of life information at pre-cell infusion and days +30, +60, and +90 from children (N = 140) receiving hematopoietic stem cell transplantation and chimeric antigen receptor T-cell therapy. A longitudinal parallel process model was used to characterize the relationship between symptoms and quality of life. RESULTS: Children (mean age, 8.4 years) received allogeneic transplant (57.9%), autologous transplant (25.7%), or chimeric antigen receptor T-cell therapy (16.4%). Symptom prevalence was highest at baseline (>50%) for pain, fatigue, nausea, vomiting, and low appetite. Quality of life scores were worse at baseline (mean [SD], 69.5 [15.8]) and improved by 10 points by day +90. The longitudinal model indicated high symptom prevalence at baseline predicted worse quality of life at both baseline and day +90. CONCLUSIONS: Children felt worse early in the treatment trajectory and improved by day +90. The level of symptom burden predicted the overall quality of life at all time points. IMPLICATIONS FOR PRACTICE: Children experiencing high symptom burden should receive frequent assessment and enhanced symptom management throughout the treatment trajectory to mitigate negative impacts on quality of life.
科研通智能强力驱动
Strongly Powered by AbleSci AI